300122.SZ
300122.SZ
CNE100000V20
ZHIFEI-BIOL
Loading chart...

Company Profile

Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vaccine. It also provides cold storage, refrigerated vehicles, and cold roll boxes; and customs clearance and registration of imported vaccines. The company was founded in 2002 and is based in Chongqing, China.

Related stocks

9995.HK
9995.HK • China
REMEGEN
70.4 HKD
5.34B USD 1Y -33.7%
1530.HK
1530.HK • China
3SBIO
15.07 HKD
4.76B USD 1Y -47.3%
688180.SS
688180.SS • China
SHANGHAI JUNSHI BIOSCIENCES CO
33.83 CNY
5.19B USD 1Y -17.6%
688336.SS
688336.SS • China
SUNSHINE GUOJIAN PHARMACEUTICAL
38.1 CNY
5.11B USD 1Y +4.2%
002252.SZ
002252.SZ • China
SHANGHAI RAAS
5.06 CNY
4.99B USD 1Y -25.4%
002007.SZ
002007.SZ • China
HUALAN BIO.
13.35 CNY
3.65B USD 1Y -17.6%
2696.HK
2696.HK • China
HENLIUS
50.75 HKD
3.53B USD 1Y -33%
603392.SS
603392.SS • China
BEIJING WANTAI BIOLOGICAL PHARM
26.96 CNY
5.1B USD 1Y -53.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
46.6% p.a.
Max Drawdown (5Y)
-88.4%
Sharpe Ratio (5Y)
-0.74
Beta Factor
0.44
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (46.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.2% in the extended horizon.
ende